Skip to main content

Avacta Group plc

This organization does not yet have a description.

Content by Avacta Group plc

Avacta Group plc TMAC programme accelerates: clinical trial planned for early 2020

Avacta and Oncosec to Collaborate on Innovative Gene Delivery of Therapeutic Affimers

Avacta Group plc announces positive outcome of proof-of-concept study with Glythera and follow-on drug development partnership

Avacta: Anti di-Ubiquitin K6 and K33 Affimers

World-leading cancer stem cell expert joins Avacta Scientific Advisory Board

Avacta Rapidly Generates Affimer Binders for Zika Virus Diagnostics

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
From Pilot to Practice: Advancing Regulatory Reliance

From Pilot to Precedent: A Year of Regulatory Innovation through PRISM and What it Means for Cloud Adoption in Regulatory Submissions

DNAnexus
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Improving Western Blot Analysis of Biofluid Samples

Improving Western Blot Analysis of Biofluid Samples

Bio-Rad
Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter

Products

Sino Biological Logo

Sino Biological Advances AI-Designed Molecule Validation with 4RISE™

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation